Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial
Diabetes Care
.
2018 Jan;41(1):e4-e5.
doi: 10.2337/dc17-1551.
Epub 2017 Nov 13.
Authors
Silvio E Inzucchi
1
,
Hristo Iliev
2
,
Egon Pfarr
2
,
Bernard Zinman
3
Affiliations
1
Section of Endocrinology, Yale School of Medicine, New Haven, CT silvio.inzucchi@yale.edu.
2
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
3
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and Division of Endocrinology and Metabolism, University of Toronto, Toronto, Canada.
PMID:
29133344
DOI:
10.2337/dc17-1551
No abstract available
Publication types
Letter